Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Buchbinder%2C+Elizabeth+I%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Buchbinder%2C+Elizabeth+I%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Buchbinder%2C+Elizabeth+I%22&type=Person&sort=year
PubPharm (100)
1
Specific oncogene activation of the cell of origin in mucosal melanoma
enthalten in:
bioRxiv.org
| 2024
von
Babu, S.
|
Chen, J.
|
Robitschek, E.
| +19
Wird geladen...
2
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?
enthalten in:
Cancer journal (Sudbury, Mass.)
| 2024
von
Fishman, J.
|
Buchbinder, E.
Wird geladen...
3
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942) : a randomised, phase 2b study
enthalten in:
Lancet (London, England)
| 2024
von
Weber, J.
|
Carlino, M.
|
Khattak, A.
| +31
Wird geladen...
4
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
enthalten in:
Seminars in arthritis and rheumatism
| 2024
von
McCarter, K.
|
Arabelovic, S.
|
Wang, X.
| +13
Wird geladen...
5
Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer
enthalten in:
Cancers
| 2024
von
Dougan, M.
|
Nguyen, L.
|
Buchbinder, E.
| +1
Wird geladen...
6
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
enthalten in:
Advances in radiation oncology
| 2024
von
Smart, A.
|
Giobbie-Hurder, A.
|
Desai, V.
| +8
Wird geladen...
7
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
enthalten in:
Cancer immunology, immunotherapy : CII
| 2024
von
Baginska, J.
|
Nau, A.
|
Gomez Diaz, I.
| +19
Wird geladen...
8
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
enthalten in:
Cancer immunology immunotherapy
| 2024
von
Baginska, J.
|
Nau, A.
|
Gomez Diaz, I.
| +19
Wird geladen...
9
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
enthalten in:
Journal for immunotherapy of cancer
| 2023
von
Pavlick, A.
|
Ariyan, C.
|
Buchbinder, E.
| +20
Wird geladen...
10
A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma
enthalten in:
Investigational new drugs
| 2023
von
Buchbinder, E.
|
Giobbie-Hurder, A.
|
Haq, R.
| +1
Wird geladen...
1
2
3
4
5
6
7
8
9
10
Nächster »
[10]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
100
Aufsätze
88
E-Artikel
88
E-Ressourcen
12
Gedruckte Aufsätze
Zeitschriftentitel
8
Investigational new drugs
8
Journal of neuro-oncology
6
Journal for ImmunoTherapy of Cancer
5
Cancer
5
Journal for immunotherapy of cancer
4
Cancer immunology immunotherapy
3
American journal of clinical oncology
3
Current oncology reports
3
Hematology/oncology clinics of North America
3
bioRxiv.org
2
Cancer discovery
2
Cancer immunology research
2
Cancer immunology, immunotherapy : CII
2
Cancer journal (Sudbury, Mass.)
2
Cancer medicine
2
Cancers
2
Clinical therapeutics
2
European journal of cancer (Oxford, England : 1...
2
JAMA oncology
2
Journal of cutaneous pathology
Alle anzeigen ...
weniger ...
Thema
59
Journal Article
36
Melanoma
21
Research Support, Non-U.S. Gov't
16
Ipilimumab
15
Immunotherapy
14
Research Support, N.I.H., Extramural
13
Review
12
DPT0O3T46P
12
Immune Checkpoint Inhibitors
12
Programmed Cell Death 1 Receptor
12
pembrolizumab
11
Antineoplastic Agents, Immunological
10
Antibodies, Monoclonal, Humanized
9
31YO63LBSN
9
Nivolumab
9
immunotherapy
9
melanoma
8
Antineoplastic Agents
8
BRAF inhibition
8
CSF1R inhibition
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
51
2020-
49
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
97
Englisch
Haven't found what you're looking for?
Wird geladen...